USP India to conduct ‘Development and Validation of Dissolution Procedure’ course from Feb 20 & 21
The United States Pharmacopoeia India Private Limited (USP-India), a non profit global health organization is planning to organize a two day course on ‘Development and validation of dissolution procedure’ in Delhi and Mumbai in the coming week.
USP India is playing a vital role in creating and promoting quality standards for medicines, herbal medicines/dietary supplements and food ingredients, and helping many pharma and biotechnology to improve their standards by giving training and awareness programmes across different parts of the country.
As a part of this initiative, USP India is fast gearing up to conduct a two day on “Development and Validation of Dissolution Procedure which is scheduled to be held on February 20&21, 2014 in New Delhi and February 24&25, 2014 in Mumbai.
The two day education programme is aimed at scientists, chemists, and lab technicians who perform dissolution testing in the lab, lab managers, QC, as well as product development professional who review dissolution data. These individuals should have a good grasp of how to execute basic dissolution testing and USP aims impart such knowledge to them through this new course.
Some of the key learning objectives of the programme include, development of dissolution and drug release testing methods based on physico-chemical characterization of APIs, physiological considerations when setting up tests, selection of dissolution testing conditions, including instruments and media, setting acceptance criteria, interpretation of dissolution test results and validation of dissolution procedures and drug release methods.
“USP courses are developed by USP Subject Matter Experts and scientists who help support the setting of USP standards followed in more than 140 countries and presented by USP Approved Instructors. All the scientists at USP have practical first hand knowledge of specific subject areas and proven professional presentation skills suited for the pharmaceutical industry,” observed Dr Erika Stippler, director, Dosage Form Performance Laboratory, United States Pharmacopoeia. Dr Erika will be the faculty for “Development and Validation of Dissolution Procedure” course in New Delhi and Mumbai.